Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10821375 Continuous production of particles

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
March 30, 2016
Date of Patent
November 3, 2020
Patent Application Number
15562823
Patent Citations Received
‌
US Patent 11998548 Amorphous nilotinib microparticles and uses thereof
0
‌
US Patent 12016861 Amorphous nilotinib microparticles and uses thereof
0
‌
US Patent 11559485 Orally disintegrating tablet comprising amorphous solid dispersion of nilotinib
‌
US Patent 11633398 Amorphous solid dispersions of dasatinib and uses thereof
0
‌
US Patent 11298356 Amorphous solid dispersions of dasatinib and uses thereof
‌
US Patent 11752105 Spray drying process with continuous preparation of spray solution
‌
US Patent 11324745 Amorphous solid dispersions of dasatinib and uses thereof
‌
US Patent 11389450 Amorphous nilotinib microparticles and uses thereof
‌
US Patent 11413290 Amorphous solid dispersions of dasatinib and uses thereof
‌
US Patent 11980619 Pharmaceutical compositions and crushable tablets including amorphous solid dispersions of dasatinib and uses
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10821375
Patent Primary Examiner
‌
Andrew S Rosenthal

Find more entities like US Patent 10821375 Continuous production of particles

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.